<?xml version="1.0" encoding="UTF-8"?>
<Label drug="cortef" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

    Fluid and Electrolyte Disturbances

  Sodium retentionFluid retentionCongestive heart failure in susceptible patientsPotassium lossHypokalemic alkalosisHypertension



   Musculoskeletal

  Muscle weaknessSteroid myopathyLoss of muscle massOsteoporosisTendon rupture, particularly of the Achilles tendonVertebral compression fracturesAseptic necrosis of femoral and humeral headsPathologic fracture of long bones



   Gastrointestinal

  Peptic ulcer with possible perforation and hemorrhagePancreatitisAbdominal distentionUlcerative esophagitisIncreases in alanine transaminase (ALT, SGPT), aspartate transaminase (AST, SGOT) and alkaline phosphatase have been observed following corticosteroid treatment. These changes are usually small, not associated with any clinical syndrome and are reversible upon discontinuation.



   Dermatologic

  Impaired wound healingThin fragile skinPetechiae and ecchymosesFacial erythemaIncreased sweatingMay suppress reactions to skin tests



   Neurological

  Increased intracranial pressure with papilledema (pseudotumor cerebri) usually after treatmentConvulsionsVertigoHeadache



   Endocrine

  Development of Cushingoid stateSuppression of growth in childrenSecondary adrenocortical and pituitary unresponsiveness, particularly in times of stress, as in trauma, surgery or illnessMenstrual irregularitiesDecreased carbohydrate toleranceManifestations of latent diabetes mellitusIncreased requirements for insulin or oral hypoglycemic agents in diabetics



   Ophthalmic

  Posterior subcapsular cataractsIncreased intraocular pressureGlaucomaExophthalmos



   Metabolic

  Negative nitrogen balance due to protein catabolism
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
